Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

George Chiou Cy
Additional contact information
George Chiou Cy: Texas A&M University Health Science Center Houston,USA

Global Journal of Pharmacy & Pharmaceutical Sciences, 2018, vol. 5, issue 5, 126-127

Abstract: The worldwide prevalence of diabetic retinopathy (DR) is at a staggeringly high level, 127 M patients in 2010 and will grow to 191 M by 2030. It is a leading cause of blindness in working-age populations [1]. Obviously, an ideal potent and safe drug is urgently needed for its treatment. However, none is available despite utmost efforts have been made by numerous research institutions. Current treatment of DR includes anti-VEGF for angiogenesis suppression; intravitreal steroid injection for inflammation inhibition; laser surgery for stopping vascular leakage; and vitrectomy for hypoxia [2-5]. None of these treatments are ideal as they are invasive in delivery and disliked by patients. Besides, VEGF is an essential ingredient for normal formation and function of blood vessels and thus a complete elimination with VEGF inhibitors could cause serious adverse effects, whereas steroid injection causes systemic side effects which are resisted by both patients and doctors. Thus, even though various means are available, there is only one, VEGF inhibitors, that is preferentially used at the present time.

Keywords: juniper publishers:Journal of Pharmacy; Global Journal of Pharmacy; Pharmaceutical Sciences; Pharmacy & Pharmaceutical Sciences; pharmaceutical sciences journals; omics online; open access; drug discovery; Clinical Trials; juniper publishers open access journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555674.pdf (application/pdf)
https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555674.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjpps:v:5:y:2018:i:5:p:126-127

DOI: 10.19080/GJPPS.2018.05.555674

Access Statistics for this article

Global Journal of Pharmacy & Pharmaceutical Sciences is currently edited by Sophia Mathis

More articles in Global Journal of Pharmacy & Pharmaceutical Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().